Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Pathfinder Cell Therapy, Inc. | f10k2014ex32i_pathfinder.htm |
| EX-31.1 - CERTIFICATION - Pathfinder Cell Therapy, Inc. | f10k2014ex31i_pathfinder.htm |
| EX-31.2 - CERTIFICATION - Pathfinder Cell Therapy, Inc. | f10k2014ex31ii_pathfinder.htm |
| EX-10.5A - COMPENSATION ARRANGEMENT WITH DR. RICHARD L. FRANKLIN, MD - Pathfinder Cell Therapy, Inc. | f10k2014ex10va_pathfinder.htm |
| EX-10.19 - FORM OF PROMISSORY NOTE - Pathfinder Cell Therapy, Inc. | f10k2014ex10xix_pathfinder.htm |
| EX-10.20A - COMPENSATION ARRANGEMENT WITH JOHN BENSON - Pathfinder Cell Therapy, Inc. | f10k2014ex10xxa_pathfinder.htm |
| EX-10.12(B) - EXTENSION NO. 3 TO RESEARCH AGREEMENT - Pathfinder Cell Therapy, Inc. | f10k2014ex10xiib_pathfinder.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Pathfinder Cell Therapy, Inc. | Financial_Report.xls |
| EX-32.2 - CERTIFICATION - Pathfinder Cell Therapy, Inc. | f10k2014ex32ii_pathfinder.htm |
| 10-K - ANNUAL REPORT - Pathfinder Cell Therapy, Inc. | f10k2014_pathfinder.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Pathfinder Cell Therapy, Inc. (the "Company") on Form S-3 (Nos. 333-147184, 333-146493 and 333-19195) and Form S-8 (Registration Nos. 333-95127, 333-95129, 333-91386 and 333-134608) of our report (which included explanatory language relating to the Company's ability to continue as a going concern) dated March 31, 2015, on our audits of the consolidated financial statements as of December 31, 2014 and 2013 and for each of the years then ended which report is included in this Annual Report on Form 10-K to be filed on or about March 31, 2015.
/s/ EisnerAmper LLP
New York, New York
March 31, 2015